ABCG2 and colonic neoplasm: Consequently, we used an immunofluorescence assay to determine if poziotinib altered the membrane localization of the ABCG2 and ABCB1 transporters in drug-resistant S1-M1-80 and SW620/Ad300 colon cancer cells, respectively.